InsidersTradesSigma
Track the ゼリア新薬工業株式会社 share price and the full insider trade history of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, ゼリア新薬工業株式会社 has published 5 insider filings. Market capitalisation: €92.1bn. The latest transaction was reported on 29 July 2024 (Holding update). Among the most active insiders: Mitsubishi UFJ Financial Group Inc.. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,313 of 29,053 companies
72.5
score / 100
Value80
Quality65
FCF yld7.6%
Earn yld9.1%
EV/EBITDA6.9x
ROE8.4%
Gross mgn73%
Net mgn9.5%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 July 2024
Declarations5 total
ShareXTKSEDINET:S100U3FU
100.0% of flowShareXTKSEDINET:S100T8HR
0.0049% mcap61.6% of flowShareXTKSEDINET:S100O7UL
1,532,800 shares0.0031% mcap38.4% of flowShareXTKSEDINET:S100MDSY
5 of 5 declarations
关于 ゼリア新薬工業株式会社
Zeria Pharmaceutical Co., Ltd. 是一家日本公司，专注于健康和制药领域。它致力于创新药物的研发和营销。